Body dysmorphic disorder in different settings: A systematic review and estimated weighted prevalence.

Our aim was to systematically review the prevalence of body dysmorphic disorder (BDD) in a variety of settings. Weighted prevalence estimate and 95% confidence intervals in each study were calculated. The weighted prevalence of BDD in adults in the community was estimated to be 1.

Preliminary studies of the ICD-11 classification of personality disorder in practice.

Objective: This study aims to compare ICD-10 and putative ICD-11 classifications of personality disorder in different clinical populations.

Design: Prospective recording of ICD-10 and ICD-11 personality disorder classifications was carried out in (1) an anxious medical population, (2) an acute psychiatric in-patient population and (3) a retrospective recording of a mixed anxiety depression cohort in which all baseline data were scored from baseline information using the ICD-11 classification and compared with the original ICD-10 assessments.

Method: Comparison of ICD-10 and ICD-11 prevalence of personality disorder in each population was carried out.

Hyperprolactinemia in a patient with a pituitary adenoma receiving antipsychotic drug therapy.

Hyperprolactinemia is a common consequence of treatment with an antipsychotic medication. It can result in hypogonadism due to the inhibitory effect of elevated prolactin levels on the hypothalamic-pituitary-gonadal hormonal axis. We present a case of hypogonadism secondary to hyperprolactinemia in a patient taking antipsychotic medication, with radiological evidence of a pituitary microadenoma.